Amedisys Top Management

Amedisys' latest congressional trading

Amedisys Management Team Effectiveness

The company has return on total asset (ROA) of 0.0652 % which means that it generated a profit of $0.0652 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0667 %, meaning that it created $0.0667 on every $100 dollars invested by stockholders. Amedisys' management efficiency ratios could be used to measure how well Amedisys manages its routine affairs as well as how well it operates its assets and liabilities. Amedisys holds a total of 32.89 Million outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or is about to change at the company. On September 15, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of Amedisys's common stock. Some institutional investors establish a significant position in stocks such as Amedisys in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Amedisys, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Amedisys Workforce Comparison

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.

Amedisys Insider Trading

Amedisys Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Amedisys often depends on how effective the management is. Amedisys management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amedisys management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amedisys management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Amedisys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amedisys' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amedisys' management manipulating its earnings.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

If you are still planning to invest in Amedisys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedisys' history and understand the potential risks before investing.